{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:57:25Z","timestamp":1788188245712,"version":"build-2803163510"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s13668-019-00286-0","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T13:49:41Z","timestamp":1562852981000},"page":"281-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Endocrine Role of Bone in Cardiometabolic Health"],"prefix":"10.1007","volume":"8","author":[{"given":"Rosemary","family":"DeLuccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Ramadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Aljahdali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeptha","family":"Sukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"9021314","DOI":"10.1155\/2017\/9021314","volume":"2017","author":"TAP Fernandes","year":"2017","unstructured":"Fernandes TAP, Goncalves LML, Brito JAA. Relationships between bone turnover and energy metabolism. J Diabetes Res. 2017;2017:9021314. https:\/\/doi.org\/10.1155\/2017\/9021314 .","journal-title":"J Diabetes Res"},{"issue":"1","key":"286_CR2","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/joe-14-0584","volume":"225","author":"KJ Oldknow","year":"2015","unstructured":"Oldknow KJ, MacRae VE, Farquharson C. Endocrine role of bone: recent and emerging perspectives beyond osteocalcin. J Endocrinol. 2015;225(1):R1\u201319. https:\/\/doi.org\/10.1530\/joe-14-0584 .","journal-title":"J Endocrinol"},{"issue":"1","key":"286_CR3","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/joe-17-0147","volume":"234","author":"KJ Suchacki","year":"2017","unstructured":"Suchacki KJ, Roberts F, Lovdel A, Farquharson C, Morton NM, MacRae VE, et al. Skeletal energy homeostasis: a paradigm of endocrine discovery. J Endocrinol. 2017;234(1):R67\u2013r79. https:\/\/doi.org\/10.1530\/joe-17-0147 .","journal-title":"J Endocrinol"},{"key":"286_CR4","doi-asserted-by":"publisher","first-page":"634195","DOI":"10.1155\/2012\/634195","volume":"2012","author":"CC Sung","year":"2012","unstructured":"Sung CC, Liao MT, Lu KC, Wu CC. Role of vitamin D in insulin resistance. J Biomed Biotechnol. 2012;2012:634195. https:\/\/doi.org\/10.1155\/2012\/634195 .","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"286_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.maturitas.2009.12.013","volume":"65","author":"J Parker","year":"2010","unstructured":"Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65(3):225\u201336. https:\/\/doi.org\/10.1016\/j.maturitas.2009.12.013 .","journal-title":"Maturitas."},{"issue":"3","key":"286_CR6","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1210\/jc.2003-031398","volume":"89","author":"SJ Parikh","year":"2004","unstructured":"Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196\u20139. https:\/\/doi.org\/10.1210\/jc.2003-031398 .","journal-title":"J Clin Endocrinol Metab"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1475-2891-11-78","volume":"11","author":"A Salehpour","year":"2012","unstructured":"Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, et al. A 12-week double-blind randomized clinical trial of vitamin D(3) supplementation on body fat mass in healthy overweight and obese women. Nutr J. 2012;11:78. https:\/\/doi.org\/10.1186\/1475-2891-11-78 .","journal-title":"Nutr J"},{"issue":"3","key":"286_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319\u201329. https:\/\/doi.org\/10.1016\/j.chembiol.2013.12.016 .","journal-title":"Chem Biol"},{"issue":"4","key":"286_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/jgs.14049","volume":"64","author":"C Mason","year":"2016","unstructured":"Mason C, Tapsoba JD, Duggan C, Imayama I, Wang CY, Korde L, et al. Effects of vitamin D3 supplementation on lean mass, muscle strength, and bone mineral density during weight loss: a double-blind randomized controlled trial. J Am Geriatr Soc. 2016;64(4):769\u201378. https:\/\/doi.org\/10.1111\/jgs.14049 .","journal-title":"J Am Geriatr Soc"},{"key":"286_CR10","doi-asserted-by":"publisher","unstructured":"Bislev LS, Langagergaard Rodbro L, Rolighed L, Sikjaer T, Rejnmark L. Effects of vitamin D3 supplementation on muscle strength, mass, and physical performance in women with vitamin D insufficiency: a randomized placebo-controlled trial. Calcif Tissue Int. 2018. https:\/\/doi.org\/10.1007\/s00223-018-0443-z . This randomized placebo-controlled trial examined the effects of vitamin D3 supplementation on muscle strength, physical performance, postural stability, well-being, and quality of life in healthy postmenopausal women with poor vitamin D status, and determined nonsignificant unfavorable outcomes of vitamin D3 supplementation on muscle strength and physical performance, and no beneficial effects on any additional outcomes.","DOI":"10.1007\/s00223-018-0443-z"},{"issue":"1","key":"286_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12887-017-0851-7","volume":"17","author":"A Szlagatys-Sidorkiewicz","year":"2017","unstructured":"Szlagatys-Sidorkiewicz A, Brzezinski M, Jankowska A, Metelska P, Slominska-Fraczek M, Socha P. Long-term effects of vitamin D supplementation in vitamin D deficient obese children participating in an integrated weight-loss programme (a double-blind placebo-controlled study) - rationale for the study design. BMC Pediatr. 2017;17(1):97. https:\/\/doi.org\/10.1186\/s12887-017-0851-7 .","journal-title":"BMC Pediatr"},{"issue":"3","key":"286_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12020-018-1665-6","volume":"61","author":"C Karefylakis","year":"2018","unstructured":"Karefylakis C, Sarnblad S, Ariander A, Ehlersson G, Rask E, Rask P. Effect of Vitamin D supplementation on body composition and cardiorespiratory fitness in overweight men-a randomized controlled trial. Endocrine. 2018;61(3):388\u201397. https:\/\/doi.org\/10.1007\/s12020-018-1665-6 . This prospective placebo-controlled, double blinded, randomized trial of overweight\/obese men with vitamin D deficiency determined that 2000 IU of cholecalciferol given over 6 months resulted in no significant improvements in body composition.","journal-title":"Endocrine"},{"issue":"7","key":"286_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4239\/wjd.v6.i7.896","volume":"6","author":"RC Strange","year":"2015","unstructured":"Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes. 2015;6(7):896\u2013911. https:\/\/doi.org\/10.4239\/wjd.v6.i7.896 .","journal-title":"World J Diabetes"},{"issue":"2","key":"286_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3945\/ajcn.111.011684","volume":"94","author":"J Mitri","year":"2011","unstructured":"Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486\u201394. https:\/\/doi.org\/10.3945\/ajcn.111.011684 .","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"286_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1464-5491.2008.02636.x","volume":"26","author":"J Nagpal","year":"2009","unstructured":"Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26(1):19\u201327. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02636.x .","journal-title":"Diabet Med"},{"key":"286_CR16","doi-asserted-by":"publisher","unstructured":"Trummer C, Theiler-Schwetz V, Kollmann M, Wolfler M, Munzker J, Pilz S, et al. Effects of vitamin D supplementation on metabolic and endocrine parameters in healthy premenopausal women: a randomized controlled trial. Clin Nutr (Edinburgh, Scotland). 2019. https:\/\/doi.org\/10.1016\/j.clnu.2019.03.007 . This double-blind, randomized placebo-controlled trial conducted in premenopausal women with poor vitamin D status determined that 20,000 IU of cholecalciferol given over 24 weeks resulted in a significant effect on the homeostatic model assessment-insulin resistance (HOMA-IR) and the quantitative-insulin-sensitivity check index (QUICKI), supporting improved endocrine functioning.","DOI":"10.1016\/j.clnu.2019.03.007"},{"issue":"8","key":"286_CR17","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1111\/j.1464-5491.2012.03672.x","volume":"29","author":"PS George","year":"2012","unstructured":"George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142\u201350. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03672.x .","journal-title":"Diabet Med"},{"key":"286_CR18","doi-asserted-by":"publisher","unstructured":"Legarth C, Grimm D, Wehland M, Bauer J, Kruger M. The Impact of Vitamin D in the Treatment of Essential Hypertension. International journal of molecular sciences. 2018;19(2). https:\/\/doi.org\/10.3390\/ijms19020455 .","DOI":"10.3390\/ijms19020455"},{"issue":"11","key":"286_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jash.2015.08.009","volume":"9","author":"S Chen","year":"2015","unstructured":"Chen S, Sun Y, Agrawal DK. Vitamin D deficiency and essential hypertension. J Am Soc Hypertens. 2015;9(11):885\u2013901. https:\/\/doi.org\/10.1016\/j.jash.2015.08.009 .","journal-title":"J Am Soc Hypertens"},{"issue":"7","key":"286_CR20","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/jc.2011-0398","volume":"96","author":"MB Elamin","year":"2011","unstructured":"Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(7):1931\u201342. https:\/\/doi.org\/10.1210\/jc.2011-0398 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"286_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","volume":"175","author":"LA Beveridge","year":"2015","unstructured":"Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med. 2015;175(5):745\u201354. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0237 .","journal-title":"JAMA Intern Med"},{"issue":"23","key":"286_CR22","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/circulationaha.113.002654","volume":"128","author":"E Kassi","year":"2013","unstructured":"Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128(23):2517\u201331. https:\/\/doi.org\/10.1161\/circulationaha.113.002654 .","journal-title":"Circulation."},{"issue":"2","key":"286_CR23","doi-asserted-by":"publisher","first-page":"e57647","DOI":"10.1371\/journal.pone.0057647","volume":"8","author":"T Skaaby","year":"2013","unstructured":"Skaaby T, Husemoen LL, Martinussen T, Thyssen JP, Melgaard M, Thuesen BH, et al. Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One. 2013;8(2):e57647. https:\/\/doi.org\/10.1371\/journal.pone.0057647 .","journal-title":"PLoS One"},{"key":"286_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/9781118453926.ch22","volume-title":"Regulation of calcium and magnesium","author":"MJ Favus","year":"2013","unstructured":"Favus MJ, Goltzman D. Regulation of calcium and magnesium. Hoboken: John Wiley & Sons, Inc.; 2013."},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/9781118453926.ch26","volume-title":"Parathyroid Hormone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"RAJ Nissenson","year":"2013","unstructured":"Nissenson RAJ, Juppner H. Parathyroid Hormone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Hoboken: John Wiley & Sons, Inc.; 2013. p. 208\u201314."},{"issue":"3","key":"286_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1677\/joe.1.06057","volume":"187","author":"JT Potts","year":"2005","unstructured":"Potts JT. Parathyroid hormone: past and present. J Endocrinol. 2005;187(3):311\u201325. https:\/\/doi.org\/10.1677\/joe.1.06057 .","journal-title":"J Endocrinol"},{"issue":"2","key":"286_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11914-012-0098-z","volume":"10","author":"DD Bikle","year":"2012","unstructured":"Bikle DD. Vitamin D and bone. Curr Osteoporos Rep. 2012;10(2):151\u20139. https:\/\/doi.org\/10.1007\/s11914-012-0098-z .","journal-title":"Curr Osteoporos Rep"},{"issue":"Suppl 1","key":"286_CR28","doi-asserted-by":"publisher","first-page":"i2","DOI":"10.1093\/ndtplus\/sfm037","volume":"1","author":"JB Cannata-Andia","year":"2008","unstructured":"Cannata-Andia JB, Carrera F. The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. NDT Plus. 2008;1(Suppl 1):i2\u20136. https:\/\/doi.org\/10.1093\/ndtplus\/sfm037 .","journal-title":"NDT Plus"},{"issue":"4","key":"286_CR29","doi-asserted-by":"publisher","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","volume":"292","author":"G Rashid","year":"2007","unstructured":"Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Ren Physiol. 2007;292(4):F1215\u20138. https:\/\/doi.org\/10.1152\/ajprenal.00406.2006 .","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"286_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/jci111971","volume":"76","author":"NH Bell","year":"1985","unstructured":"Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985;76(1):370\u20133. https:\/\/doi.org\/10.1172\/jci111971 .","journal-title":"J Clin Invest"},{"issue":"3","key":"286_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bone.2005.08.018","volume":"38","author":"MJ Bolland","year":"2006","unstructured":"Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone. 2006;38(3):317\u201321. https:\/\/doi.org\/10.1016\/j.bone.2005.08.018 .","journal-title":"Bone."},{"issue":"3","key":"286_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.metabol.2009.08.007","volume":"59","author":"G Saab","year":"2010","unstructured":"Saab G, Whaley-Connell A, McFarlane SI, Li S, Chen SC, Sowers JR, et al. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metab Clin Exp. 2010;59(3):385\u20139. https:\/\/doi.org\/10.1016\/j.metabol.2009.08.007 .","journal-title":"Metab Clin Exp"},{"issue":"6","key":"286_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.4103\/ijem.IJEM_42_17","volume":"21","author":"RK Marwaha","year":"2017","unstructured":"Marwaha RK, Garg MK, Mahalle N, Bhadra K, Tandon N. Role of parathyroid hormone in determination of fat mass in patients with vitamin D deficiency. Indian J Endocrinol Metabol. 2017;21(6):848\u201353. https:\/\/doi.org\/10.4103\/ijem.IJEM_42_17 .","journal-title":"Indian J Endocrinol Metabol"},{"issue":"10","key":"286_CR34","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V10102158","volume":"10","author":"U Querfeld","year":"1999","unstructured":"Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D, et al. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol. 1999;10(10):2158\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"286_CR35","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/S0021-9258(18)53700-5","volume":"268","author":"JE Reusch","year":"1993","unstructured":"Reusch JE, Sussman KE, Draznin B. Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity. J Biol Chem. 1993;268(5):3348\u201351.","journal-title":"J Biol Chem"},{"key":"286_CR36","doi-asserted-by":"publisher","unstructured":"Lotito A, Teramoto M, Cheung M, Becker K, Sukumar D. Serum parathyroid hormone responses to vitamin D supplementation in overweight\/obese adults: a systematic review and meta-analysis of randomized clinical trials. Nutrients. 2017;9(3). https:\/\/doi.org\/10.3390\/nu9030241 .","DOI":"10.3390\/nu9030241"},{"issue":"1","key":"286_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cen.13861","volume":"90","author":"L Lotfi-Dizaji","year":"2019","unstructured":"Lotfi-Dizaji L, Mahboob S, Aliashrafi S, Vaghef-Mehrabany E, Ebrahimi-Mameghani M, Morovati A. Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: a double-blind placebo-controlled randomized clinical trial. Clin Endocrinol. 2019;90(1):94\u2013101. https:\/\/doi.org\/10.1111\/cen.13861 .","journal-title":"Clin Endocrinol"},{"issue":"3","key":"286_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/0100-69912017003007","volume":"44","author":"HG Valente-Da-Silva","year":"2017","unstructured":"Valente-Da-Silva HG, Maya MCA, Moreira AS. Parathyroidectomy in chronic kidney disease: effects on weight gain and on quality of life improvement. Revista do Colegio Brasileiro de Cirurgioes. 2017;44(3):263\u20139. https:\/\/doi.org\/10.1590\/0100-69912017003007 . This longitudinal study of hemodialysis patients with severe secondary parathyroidism demonstrated that parathyroidectomy resulted in significant increases in body weight and body cell mass with stabilization of intact parathyroid hormone concentrations after surgery.","journal-title":"Revista do Colegio Brasileiro de Cirurgioes"},{"issue":"1","key":"286_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/sj.ijo.0803066","volume":"30","author":"CW Gunther","year":"2006","unstructured":"Gunther CW, Legowski PA, Lyle RM, Weaver CM, McCabe LD, McCabe GP, et al. Parathyroid hormone is associated with decreased fat mass in young healthy women. Int J Obes. 2006;30(1):94\u20139. https:\/\/doi.org\/10.1038\/sj.ijo.0803066 .","journal-title":"Int J Obes"},{"issue":"3","key":"286_CR40","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1210\/jc.2012-3883","volume":"98","author":"E Ishimura","year":"2013","unstructured":"Ishimura E, Okuno S, Tsuboniwa N, Norimine K, Fukumoto S, Yamakawa K, et al. Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients. J Clin Endocrinol Metab. 2013;98(3):1264\u201370. https:\/\/doi.org\/10.1210\/jc.2012-3883 .","journal-title":"J Clin Endocrinol Metab"},{"key":"286_CR41","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1038\/srep05066","volume":"4","author":"S Kimura","year":"2014","unstructured":"Kimura S, Yoshioka K. Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation. Sci Rep. 2014;4:5066. https:\/\/doi.org\/10.1038\/srep05066 .","journal-title":"Sci Rep"},{"issue":"12","key":"286_CR42","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1210\/jc.2003-030604","volume":"88","author":"M Visser","year":"2003","unstructured":"Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766\u201372. https:\/\/doi.org\/10.1210\/jc.2003-030604 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"286_CR43","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","volume":"31","author":"S Pilz","year":"2010","unstructured":"Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J. 2010;31(13):1591\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehq109 .","journal-title":"Eur Heart J"},{"issue":"8","key":"286_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2174\/1381612013397780","volume":"7","author":"P Morley","year":"2001","unstructured":"Morley P, Whitfield JF, Willick GE. Parathyroid hormone: an anabolic treatment for osteoporosis. Curr Pharm Des. 2001;7(8):671\u201387.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"286_CR45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/atvbaha.114.303637","volume":"34","author":"C Goettsch","year":"2014","unstructured":"Goettsch C, Iwata H, Aikawa E. Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34(7):1333\u20135. https:\/\/doi.org\/10.1161\/atvbaha.114.303637 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"286_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000045976","volume":"88","author":"G Coen","year":"2001","unstructured":"Coen G, Calabria S, Bellinghieri G, Pecchini F, Conte F, Chiappini MG, et al. Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia. Nephron. 2001;88(2):149\u201355. https:\/\/doi.org\/10.1159\/000045976 .","journal-title":"Nephron."},{"issue":"6","key":"286_CR47","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","volume":"146","author":"A Heyliger","year":"2009","unstructured":"Heyliger A, Tangpricha V, Weber C, Sharma J. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery. 2009;146(6):1042\u20137. https:\/\/doi.org\/10.1016\/j.surg.2009.09.024 .","journal-title":"Surgery."},{"issue":"4","key":"286_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4158\/ep10321.Or","volume":"17","author":"A Ishay","year":"2011","unstructured":"Ishay A, Herer P, Luboshitzky R. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Endocr Pract. 2011;17(4):584\u201390. https:\/\/doi.org\/10.4158\/ep10321.Or .","journal-title":"Endocr Pract"},{"issue":"10","key":"286_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0011-5029(96)90019-X","volume":"42","author":"BE Akpunonu","year":"1996","unstructured":"Akpunonu BE, Mulrow PJ, Hoffman EA. Secondary hypertension: evaluation and treatment. Dis Mon. 1996;42(10):609\u2013722.","journal-title":"Dis Mon"},{"issue":"2","key":"286_CR50","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1210\/jc.2014-3949","volume":"100","author":"J Brown","year":"2015","unstructured":"Brown J, de Boer IH, Robinson-Cohen C, Siscovick DS, Kestenbaum B, Allison M, et al. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2015;100(2):490\u20139. https:\/\/doi.org\/10.1210\/jc.2014-3949 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"286_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","volume":"30","author":"C Maniero","year":"2012","unstructured":"Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, et al. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens. 2012;30(2):390\u20135. https:\/\/doi.org\/10.1097\/HJH.0b013e32834f0451 .","journal-title":"J Hypertens"},{"issue":"1","key":"286_CR52","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1210\/jc.2011-2183","volume":"97","author":"S Pilz","year":"2012","unstructured":"Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, et al. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab. 2012;97(1):E75\u20139. https:\/\/doi.org\/10.1210\/jc.2011-2183 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"286_CR53","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-o","volume":"8","author":"E Rossi","year":"1995","unstructured":"Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens. 1995;8(9):884\u201393. https:\/\/doi.org\/10.1016\/0895-7061(95)00182-o .","journal-title":"Am J Hypertens"},{"issue":"12","key":"286_CR54","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, Magalhaes AO, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007;71(12):1262\u201370. https:\/\/doi.org\/10.1038\/sj.ki.5002241 .","journal-title":"Kidney Int"},{"issue":"6","key":"286_CR55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1067\/msy.2001.118368","volume":"130","author":"IL Nilsson","year":"2001","unstructured":"Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery. 2001;130(6):986\u201390. https:\/\/doi.org\/10.1067\/msy.2001.118368 .","journal-title":"Surgery."},{"key":"286_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/978-1-4684-4259-5_64","volume":"151","author":"M Rambausek","year":"1982","unstructured":"Rambausek M, Ritz E, Rascher W, Kreusser W, Mann JF, Kreye VA, et al. Vascular effects of parathyroid hormone (PTH). Adv Exp Med Biol. 1982;151:619\u201332.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"286_CR57","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","volume":"12","author":"D Fliser","year":"1997","unstructured":"Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, et al. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant. 1997;12(5):933\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"286_CR58","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jcem.86.4.7393","volume":"86","author":"M Pfeifer","year":"2001","unstructured":"Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633\u20137. https:\/\/doi.org\/10.1210\/jcem.86.4.7393 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"286_CR59","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/hypertensionaha.115.05319","volume":"65","author":"S Pilz","year":"2015","unstructured":"Pilz S, Gaksch M, Kienreich K, Grubler M, Verheyen N, Fahrleitner-Pammer A, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension (Dallas, Tex : 1979). 2015;65(6):1195\u2013201. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05319 .","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"5","key":"286_CR60","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/circheartfailure.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014;7(5):732\u20139. https:\/\/doi.org\/10.1161\/circheartfailure.114.001272 .","journal-title":"Circ Heart Fail"},{"issue":"11","key":"286_CR61","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ejhg.2009.61","volume":"17","author":"M van Hoek","year":"2009","unstructured":"van Hoek M, Dallinga-Thie GM, Steyerberg EW, Sijbrands EJ. Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes. Eur J Hum Genet. 2009;17(11):1386\u201393. https:\/\/doi.org\/10.1038\/ejhg.2009.61 .","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"286_CR62","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218\u201340. https:\/\/doi.org\/10.3390\/nu5041218 .","journal-title":"Nutrients."},{"issue":"8","key":"286_CR63","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/0026-0495(76)90124-4","volume":"25","author":"AM Parfitt","year":"1976","unstructured":"Parfitt AM. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metab Clin Exp. 1976;25(8):909\u201355.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"286_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/eje.1.02173","volume":"155","author":"E Hagstrom","year":"2006","unstructured":"Hagstrom E, Lundgren E, Rastad J, Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol. 2006;155(1):33\u20139. https:\/\/doi.org\/10.1530\/eje.1.02173 .","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"286_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1081\/JDI-48229","volume":"27","author":"S Zanos","year":"2005","unstructured":"Zanos S, Mitsopoulos E, Sakellariou G. Parathyroid hormone levels, calcium-channel blockers, and the dyslipidemia of nondiabetic hemodialysis patients. Ren Fail. 2005;27(2):163\u20139.","journal-title":"Ren Fail"},{"issue":"6","key":"286_CR66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1530\/eje-13-0547","volume":"169","author":"S Norenstedt","year":"2013","unstructured":"Norenstedt S, Pernow Y, Brismar K, Saaf M, Ekip A, Granath F, et al. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. Eur J Endocrinol. 2013;169(6):795\u2013804. https:\/\/doi.org\/10.1530\/eje-13-0547 .","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"286_CR67","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014;99(3):1072\u201380. https:\/\/doi.org\/10.1210\/jc.2013-3978 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"286_CR68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cen.12398","volume":"80","author":"VN Shah","year":"2014","unstructured":"Shah VN, Shah CS, Bhadada SK, Rao DS. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol. 2014;80(6):797\u2013803. https:\/\/doi.org\/10.1111\/cen.12398 .","journal-title":"Clin Endocrinol"},{"issue":"6","key":"286_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","volume":"41","author":"R Jorde","year":"2002","unstructured":"Jorde R, Szumlas K, Haug E, Sundsfjord J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur J Nutr. 2002;41(6):258\u201363. https:\/\/doi.org\/10.1007\/s00394-002-0383-1 .","journal-title":"Eur J Nutr"},{"issue":"6","key":"286_CR70","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1067\/msy.2099.101436","volume":"126","author":"ML Richards","year":"1999","unstructured":"Richards ML, Thompson NW. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery. 1999;126(6):1160\u20136.","journal-title":"Surgery."},{"issue":"1","key":"286_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009738609178495","volume":"91","author":"R Schaerstrom","year":"1986","unstructured":"Schaerstrom R, Hamfelt A, Soderhjelm L. Parathyroid hormone and calcitonin in diabetes mellitus. Ups J Med Sci. 1986;91(1):99\u2013104.","journal-title":"Ups J Med Sci"},{"issue":"4","key":"286_CR72","first-page":"319","volume":"117","author":"N Wongsurawat","year":"1991","unstructured":"Wongsurawat N, Armbrecht HJ, Siegel NA. Effects of diabetes mellitus on parathyroid hormone-stimulated protein kinase activity, ferredoxin phosphorylation, and renal 1,25-dihydroxyvitamin D production. J Lab Clin Med. 1991;117(4):319\u201324.","journal-title":"J Lab Clin Med"},{"issue":"6 Pt 1","key":"286_CR73","doi-asserted-by":"publisher","first-page":"E975","DOI":"10.1152\/ajpendo.1990.258.6.E975","volume":"258","author":"GZ Fadda","year":"1990","unstructured":"Fadda GZ, Akmal M, Lipson LG, Massry SG. Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Phys. 1990;258(6 Pt 1):E975\u201384. https:\/\/doi.org\/10.1152\/ajpendo.1990.258.6.E975 .","journal-title":"Am J Phys"},{"issue":"2","key":"286_CR74","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00298433","volume":"57","author":"AW Saxe","year":"1995","unstructured":"Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int. 1995;57(2):127\u201332.","journal-title":"Calcif Tissue Int"},{"issue":"1\u20132","key":"286_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mce.2009.03.024","volume":"307","author":"E Chang","year":"2009","unstructured":"Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol. 2009;307(1\u20132):77\u201382. https:\/\/doi.org\/10.1016\/j.mce.2009.03.024 .","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"286_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/sdi.12198","volume":"27","author":"CM Rhee","year":"2014","unstructured":"Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar-Zadeh K. Updates on the management of diabetes in dialysis patients. Semin Dial. 2014;27(2):135\u201345. https:\/\/doi.org\/10.1111\/sdi.12198 .","journal-title":"Semin Dial"},{"issue":"4","key":"286_CR77","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2337\/dc06-1994","volume":"30","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30(4):980\u20136. https:\/\/doi.org\/10.2337\/dc06-1994 .","journal-title":"Diabetes Care"},{"issue":"1","key":"286_CR78","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1748-1716.2010.02237.x","volume":"203","author":"MR Meyer","year":"2011","unstructured":"Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxford, England). 2011;203(1):259\u201369. https:\/\/doi.org\/10.1111\/j.1748-1716.2010.02237.x .","journal-title":"Acta Physiol (Oxford, England)"},{"issue":"3","key":"286_CR79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.31887\/DCNS.2009.11.3\/pmwise","volume":"11","author":"PM Wise","year":"2009","unstructured":"Wise PM, Suzuki S, Brown CM. Estradiol: a hormone with diverse and contradictory neuroprotective actions. Dialogues Clin Neurosci. 2009;11(3):297\u2013303.","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"286_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.11613\/bm.2014.035","volume":"24","author":"P Vrtacnik","year":"2014","unstructured":"Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J. The many faces of estrogen signaling. Biochem Med. 2014;24(3):329\u201342. https:\/\/doi.org\/10.11613\/bm.2014.035 .","journal-title":"Biochem Med"},{"issue":"15","key":"286_CR81","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1073\/pnas.88.15.6613","volume":"88","author":"MJ Oursler","year":"1991","unstructured":"Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A. 1991;88(15):6613\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"286_CR82","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1210\/er.2008-0002","volume":"29","author":"S Khosla","year":"2008","unstructured":"Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008;29(4):441\u201364. https:\/\/doi.org\/10.1210\/er.2008-0002 .","journal-title":"Endocr Rev"},{"issue":"5","key":"286_CR83","first-page":"719","volume":"104","author":"S Kousteni","year":"2001","unstructured":"Kousteni S, Bellido T, Plotkin LI, O\u2019Brien CA, Bodenner DL, Han L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104(5):719\u201330.","journal-title":"Cell."},{"issue":"7","key":"286_CR84","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1210\/jcem.84.7.5834","volume":"84","author":"ND Quinton","year":"1999","unstructured":"Quinton ND, Smith RF, Clayton PE, Gill MS, Shalet S, Justice SK, et al. Leptin binding activity changes with age: the link between leptin and puberty. J Clin Endocrinol Metab. 1999;84(7):2336\u201341. https:\/\/doi.org\/10.1210\/jcem.84.7.5834 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"286_CR85","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/sj.ijo.0801806","volume":"25","author":"DA Ainslie","year":"2001","unstructured":"Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord. 2001;25(11):1680\u20138. https:\/\/doi.org\/10.1038\/sj.ijo.0801806 .","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"286_CR86","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.physbeh.2009.02.017","volume":"97","author":"H Shi","year":"2009","unstructured":"Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97(2):199\u2013204. https:\/\/doi.org\/10.1016\/j.physbeh.2009.02.017 .","journal-title":"Physiol Behav"},{"key":"286_CR87","doi-asserted-by":"publisher","unstructured":"Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev. 2000;(2):Cd001018. https:\/\/doi.org\/10.1002\/14651858.Cd001018 .","DOI":"10.1002\/14651858.Cd001018"},{"issue":"3","key":"286_CR88","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/13697130903318240","volume":"13","author":"S Ziaei","year":"2010","unstructured":"Ziaei S, Moaya M, Faghihzadeh S. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women. Climacteric. 2010;13(3):249\u201353. https:\/\/doi.org\/10.3109\/13697130903318240 .","journal-title":"Climacteric"},{"issue":"1","key":"286_CR89","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/gme.0b013e3181e3aab1","volume":"18","author":"JW Bea","year":"2011","unstructured":"Bea JW, Zhao Q, Cauley JA, LaCroix AZ, Bassford T, Lewis CE, et al. Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women\u2019s Health Initiative hormone trials. Menopause (New York, NY). 2011;18(1):44\u201352. https:\/\/doi.org\/10.1097\/gme.0b013e3181e3aab1 .","journal-title":"Menopause (New York, NY)"},{"issue":"3","key":"286_CR90","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0008-6363(01)00527-2","volume":"53","author":"RK Dubey","year":"2002","unstructured":"Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688\u2013708.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"286_CR91","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1067\/mob.2001.111246","volume":"184","author":"B Cacciatore","year":"2001","unstructured":"Cacciatore B, Paakkari I, Hasselblatt R, Nieminen MS, Toivonen J, Tikkanen MI, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184(5):904\u20139. https:\/\/doi.org\/10.1067\/mob.2001.111246 .","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"286_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0378-5122(78)90003-8","volume":"1","author":"WH Utian","year":"1978","unstructured":"Utian WH. Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. Maturitas. 1978;1(1):3\u20138.","journal-title":"Maturitas."},{"issue":"6","key":"286_CR93","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/sj.bjp.0704762","volume":"136","author":"KK Lam","year":"2002","unstructured":"Lam KK, Hu CT, Ou TY, Yen MH, Chen HI. Effects of oestrogen replacement on steady and pulsatile haemodynamics in ovariectomized rats. Br J Pharmacol. 2002;136(6):811\u20138. https:\/\/doi.org\/10.1038\/sj.bjp.0704762 .","journal-title":"Br J Pharmacol"},{"issue":"3","key":"286_CR94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrneph.2017.189","volume":"14","author":"KMM Colafella","year":"2018","unstructured":"Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14(3):185\u2013201. https:\/\/doi.org\/10.1038\/nrneph.2017.189 .","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"286_CR95","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s001250050758","volume":"40","author":"HE Brussaard","year":"1997","unstructured":"Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997;40(7):843\u20139.","journal-title":"Diabetologia."},{"issue":"5","key":"286_CR96","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/BF00281829","volume":"19","author":"CJ Bailey","year":"1980","unstructured":"Bailey CJ, Ahmed-Sorour H. Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia. 1980;19(5):475\u201381.","journal-title":"Diabetologia."},{"issue":"3","key":"286_CR97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2012-1055","volume":"34","author":"F Mauvais-Jarvis","year":"2013","unstructured":"Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34(3):309\u201338. https:\/\/doi.org\/10.1210\/er.2012-1055 .","journal-title":"Endocr Rev"},{"issue":"16","key":"286_CR98","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1056\/nejm199410203311604","volume":"331","author":"EP Smith","year":"1994","unstructured":"Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(16):1056\u201361. https:\/\/doi.org\/10.1056\/nejm199410203311604 .","journal-title":"N Engl J Med"},{"issue":"6","key":"286_CR99","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/jcp.24278","volume":"228","author":"A Neve","year":"2013","unstructured":"Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228(6):1149\u201353. https:\/\/doi.org\/10.1002\/jcp.24278 .","journal-title":"J Cell Physiol"},{"key":"286_CR100","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"Research ASfBaM","year":"2013","unstructured":"Research ASfBaM. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed. Hoboken: Wiley-Blackwell; 2013.","edition":"8"},{"key":"286_CR101","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1038\/boneres.2016.4","volume":"4","author":"ML Zoch","year":"2016","unstructured":"Zoch ML, Abou DS, Clemens TL, Thorek DL, Riddle RC. In vivo radiometric analysis of glucose uptake and distribution in mouse bone. Bone Res. 2016;4:16004. https:\/\/doi.org\/10.1038\/boneres.2016.4 .","journal-title":"Bone Res"},{"issue":"4","key":"286_CR102","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/jci111308","volume":"73","author":"JB Lian","year":"1984","unstructured":"Lian JB, Tassinari M, Glowacki J. Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest. 1984;73(4):1223\u20136. https:\/\/doi.org\/10.1172\/jci111308 .","journal-title":"J Clin Invest"},{"issue":"4","key":"286_CR103","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1083\/jcb.127.4.1149","volume":"127","author":"C Chenu","year":"1994","unstructured":"Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, et al. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol. 1994;127(4):1149\u201358.","journal-title":"J Cell Biol"},{"issue":"3","key":"286_CR104","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1172\/jci117106","volume":"93","author":"RT Ingram","year":"1994","unstructured":"Ingram RT, Park YK, Clarke BL, Fitzpatrick LA. Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling. J Clin Invest. 1994;93(3):989\u201397. https:\/\/doi.org\/10.1172\/jci117106 .","journal-title":"J Clin Invest"},{"issue":"1","key":"286_CR105","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/jc.2012-2906","volume":"98","author":"Y Bao","year":"2013","unstructured":"Bao Y, Ma X, Yang R, Wang F, Hao Y, Dou J, et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J Clin Endocrinol Metab. 2013;98(1):345\u201351. https:\/\/doi.org\/10.1210\/jc.2012-2906 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"286_CR106","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/eje-09-0585","volume":"161","author":"M Zhou","year":"2009","unstructured":"Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol. 2009;161(5):723\u20139. https:\/\/doi.org\/10.1530\/eje-09-0585 .","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"286_CR107","doi-asserted-by":"publisher","first-page":"E1982","DOI":"10.1210\/jc.2011-0587","volume":"96","author":"AL Schafer","year":"2011","unstructured":"Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, et al. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1\u201384) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011;96(12):E1982\u20139. https:\/\/doi.org\/10.1210\/jc.2011-0587 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"286_CR108","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ejcn.2017.146","volume":"72","author":"MHJ Knapen","year":"2018","unstructured":"Knapen MHJ, Jardon KM, Vermeer C. Vitamin K-induced effects on body fat and weight: results from a 3-year vitamin K2 intervention study. Eur J Clin Nutr. 2018;72(1):136\u201341. https:\/\/doi.org\/10.1038\/ejcn.2017.146 . In this randomized placebo-controlled human intervention trial in postmenopausal women, 180 mcg\/day of vitamin K2 over 3 years resulted in increased circulating carboxylated osteocalcin, but had no effect on body composition. Additionally, in good responders, vitamin K2 treatment resulted in significantly increased total and human molecular weight adiponectin and decreased abdominal fat mass and estimated viseral adipose tissue area.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"286_CR109","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jbmr.2989","volume":"32","author":"MK Shea","year":"2017","unstructured":"Shea MK, Dawson-Hughes B, Gundberg CM, Booth SL. Reducing undercarboxylated osteocalcin with vitamin k supplementation does not promote lean tissue loss or fat gain over 3 years in older women and men: a randomized controlled trial. J Bone Miner Res. 2017;32(2):243\u20139. https:\/\/doi.org\/10.1002\/jbmr.2989 .","journal-title":"J Bone Miner Res"},{"issue":"2","key":"286_CR110","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/eje-10-0414","volume":"163","author":"BB Yeap","year":"2010","unstructured":"Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Beilby JP, et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol. 2010;163(2):265\u201372. https:\/\/doi.org\/10.1530\/eje-10-0414 .","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"286_CR111","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/atvbaha.110.204859","volume":"30","author":"U Saleem","year":"2010","unstructured":"Saleem U, Mosley TH Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010;30(7):1474\u20138. https:\/\/doi.org\/10.1161\/atvbaha.110.204859 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"286_CR112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/jc.2008-1455","volume":"94","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(1):45\u20139. https:\/\/doi.org\/10.1210\/jc.2008-1455 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"286_CR113","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bone.2010.11.005","volume":"48","author":"G Goliasch","year":"2011","unstructured":"Goliasch G, Blessberger H, Azar D, Heinze G, Wojta J, Bieglmayer C, et al. Markers of bone metabolism in premature myocardial infarction (<\/= 40 years of age). Bone. 2011;48(3):622\u20136. https:\/\/doi.org\/10.1016\/j.bone.2010.11.005 .","journal-title":"Bone."},{"issue":"9","key":"286_CR114","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jash.2017.07.001","volume":"11","author":"AG Mansour","year":"2017","unstructured":"Mansour AG, Hariri E, Daaboul Y, Korjian S, El Alam A, Protogerou AD, et al. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial. J Am Soc Hypertens. 2017;11(9):589\u201397. https:\/\/doi.org\/10.1016\/j.jash.2017.07.001 .","journal-title":"J Am Soc Hypertens"},{"issue":"3","key":"286_CR115","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456\u201369. https:\/\/doi.org\/10.1016\/j.cell.2007.05.047 .","journal-title":"Cell."},{"issue":"5","key":"286_CR116","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1590\/0004-2730000003333","volume":"58","author":"LC Zanatta","year":"2014","unstructured":"Zanatta LC, Boguszewski CL, Borba VZ, Kulak CA. Osteocalcin, energy and glucose metabolism. Arq Bras Endocrinol Metabol. 2014;58(5):444\u201351.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"8","key":"286_CR117","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/dmrr.1045","volume":"25","author":"YC Hwang","year":"2009","unstructured":"Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009;25(8):768\u201372. https:\/\/doi.org\/10.1002\/dmrr.1045 .","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"286_CR118","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3945\/ajcn.2009.28151","volume":"90","author":"MK Shea","year":"2009","unstructured":"Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009;90(5):1230\u20135. https:\/\/doi.org\/10.3945\/ajcn.2009.28151 .","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"286_CR119","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1210\/jc.2013-2472","volume":"98","author":"A Diaz-Lopez","year":"2013","unstructured":"Diaz-Lopez A, Bullo M, Juanola-Falgarona M, Martinez-Gonzalez MA, Estruch R, Covas MI, et al. Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study. J Clin Endocrinol Metab. 2013;98(11):4524\u201331. https:\/\/doi.org\/10.1210\/jc.2013-2472 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"286_CR120","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.550","volume":"27","author":"C Boucher-Berry","year":"2012","unstructured":"Boucher-Berry C, Speiser PW, Carey DE, Shelov SP, Accacha S, Fennoy I, et al. Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children. J Bone Miner Res. 2012;27(2):283\u201393. https:\/\/doi.org\/10.1002\/jbmr.550 .","journal-title":"J Bone Miner Res"},{"key":"286_CR121","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2015.01.002","volume":"410","author":"D Sukumar","year":"2015","unstructured":"Sukumar D, Shapses SA, Schneider SH. Vitamin D supplementation during short-term caloric restriction in healthy overweight\/obese older women: effect on glycemic indices and serum osteocalcin levels. Mol Cell Endocrinol. 2015;410:73\u20137. https:\/\/doi.org\/10.1016\/j.mce.2015.01.002 .","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"286_CR122","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00198-011-1807-7","volume":"23","author":"KM Thrailkill","year":"2012","unstructured":"Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Lumpkin CK Jr, Fowlkes JL. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int. 2012;23(6):1799\u2013806. https:\/\/doi.org\/10.1007\/s00198-011-1807-7 .","journal-title":"Osteoporos Int"},{"issue":"3","key":"286_CR123","first-page":"478","volume":"3","author":"J Masrour Roudsari","year":"2012","unstructured":"Masrour Roudsari J, Mahjoub S. Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget\u2019s specimens. Caspian J Intern Med. 2012;3(3):478\u201383.","journal-title":"Caspian J Intern Med"},{"issue":"4a","key":"286_CR124","first-page":"1853","volume":"27","author":"D Pollmann","year":"2007","unstructured":"Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Luftner D. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Anticancer Res. 2007;27(4a):1853\u201362.","journal-title":"Anticancer Res"},{"issue":"2","key":"286_CR125","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464\u201374. https:\/\/doi.org\/10.1373\/clinchem.2016.259085 .","journal-title":"Clin Chem"},{"issue":"4","key":"286_CR126","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000355807","volume":"39","author":"E Ishimura","year":"2014","unstructured":"Ishimura E, Okuno S, Okazaki H, Norimine K, Yamakawa K, Yamakawa T, et al. Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients. Kidney Blood Press Res. 2014;39(4):299\u2013307. https:\/\/doi.org\/10.1159\/000355807 .","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"286_CR127","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/PL00005830","volume":"66","author":"HN Rosen","year":"2000","unstructured":"Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, et al. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int. 2000;66(2):100\u20133.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"286_CR128","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1210\/jc.2013-3097","volume":"99","author":"H Viljakainen","year":"2014","unstructured":"Viljakainen H, Ivaska KK, Paldanius P, Lipsanen-Nyman M, Saukkonen T, Pietilainen KH, et al. Suppressed bone turnover in obesity: a link to energy metabolism? A case-control study. J Clin Endocrinol Metab. 2014;99(6):2155\u201363. https:\/\/doi.org\/10.1210\/jc.2013-3097 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"286_CR129","doi-asserted-by":"publisher","first-page":"259","DOI":"10.17305\/bjbms.2013.2337","volume":"13","author":"E Kucukalic-Selimovic","year":"2013","unstructured":"Kucukalic-Selimovic E, Valjevac A, Hadzovic-Dzuvo A. The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women. Bosnian J Basic Med Sci. 2013;13(4):259\u201365. https:\/\/doi.org\/10.17305\/bjbms.2013.2337 .","journal-title":"Bosnian J Basic Med Sci"},{"issue":"9","key":"286_CR130","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2013-2024","volume":"98","author":"CL Cheung","year":"2013","unstructured":"Cheung CL, Tan KC, Lam KS, Cheung BM. The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J Clin Endocrinol Metab. 2013;98(9):3856\u201363. https:\/\/doi.org\/10.1210\/jc.2013-2024 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"286_CR131","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00774-004-0528-9","volume":"22","author":"K Iba","year":"2004","unstructured":"Iba K, Takada J, Yamashita T. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab. 2004;22(6):594\u20136. https:\/\/doi.org\/10.1007\/s00774-004-0528-9 .","journal-title":"J Bone Miner Metab"},{"key":"286_CR132","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcme.2014.06.002","volume":"4","author":"N Fukushima","year":"2014","unstructured":"Fukushima N, Suzuki A, Fukushima K, Tanaka Y, Sato Y, Shiga T, et al. Impact of the serum bone-specific alkaline phosphatase level at the initiation of hemodialysis therapy for end-stage renal disease on cardiovascular events. IJC Metab Endocr. 2014;4:58\u201362.","journal-title":"IJC Metab Endocr"},{"issue":"7","key":"286_CR133","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.2215\/cjn.10091110","volume":"6","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, et al. Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1752\u20139. https:\/\/doi.org\/10.2215\/cjn.10091110 .","journal-title":"Clin J Am Soc Nephrol"},{"key":"286_CR134","doi-asserted-by":"crossref","unstructured":"Newton A, Hanks L, Judd S, Wallace S, Durant N, Casazza K. Low HDL cholesterol may lead to disruption of bone (re) modeling in obese early pubertal girls. Int J Orthop. 2015;2(3).","DOI":"10.17554\/j.issn.2311-5106.2015.02.81"},{"issue":"2","key":"286_CR135","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","volume":"162","author":"JL Anderson","year":"2011","unstructured":"Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappe DL, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J. 2011;162(2):331\u20139.e2. https:\/\/doi.org\/10.1016\/j.ahj.2011.05.005 .","journal-title":"Am Heart J"},{"issue":"22","key":"286_CR136","first-page":"4332","volume":"19","author":"LM Saber","year":"2015","unstructured":"Saber LM, Mahran HN, Baghdadi HH, Al Hawsawi ZM. Interrelationship between bone turnover markers, calciotropic hormones and leptin in obese Saudi children. Eur Rev Med Pharmacol Sci. 2015;19(22):4332\u201343.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"286_CR137","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1210\/jc.2008-2187","volume":"94","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, et al. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(8):3031\u20137. https:\/\/doi.org\/10.1210\/jc.2008-2187 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"286_CR138","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/jbmr.13","volume":"25","author":"P Szulc","year":"2010","unstructured":"Szulc P, Varennes A, Delmas PD, Goudable J, Chapurlat R. Men with metabolic syndrome have lower bone mineral density but lower fracture risk--the MINOS study. J Bone Miner Res. 2010;25(6):1446\u201354. https:\/\/doi.org\/10.1002\/jbmr.13 .","journal-title":"J Bone Miner Res"},{"issue":"12","key":"286_CR139","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/aps.2017.23","volume":"38","author":"J Wang","year":"2017","unstructured":"Wang J, Yan DD, Hou XH, Bao YQ, Hu C, Zhang ZL, et al. Association of bone turnover markers with glucose metabolism in Chinese population. Acta Pharmacol Sin. 2017;38(12):1611\u20137. https:\/\/doi.org\/10.1038\/aps.2017.23 .","journal-title":"Acta Pharmacol Sin"},{"issue":"11\u201312","key":"286_CR140","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.nut.2015.06.012","volume":"31","author":"M Ogata","year":"2015","unstructured":"Ogata M, Ide R, Takizawa M, Tanaka M, Tetsuo T, Sato A, et al. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes. Nutrition (Burbank, Los Angeles County, Calif). 2015;31(11\u201312):1394\u2013401. https:\/\/doi.org\/10.1016\/j.nut.2015.06.012 .","journal-title":"Nutrition (Burbank, Los Angeles County, Calif)"},{"issue":"10","key":"286_CR141","first-page":"1598","volume":"98","author":"SG Oz","year":"2006","unstructured":"Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc. 2006;98(10):1598\u2013604.","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"286_CR142","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00198-005-1877-5","volume":"16","author":"P Gerdhem","year":"2005","unstructured":"Gerdhem P, Isaksson A, Akesson K, Obrant KJ. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005;16(12):1506\u201312. https:\/\/doi.org\/10.1007\/s00198-005-1877-5 .","journal-title":"Osteoporos Int"},{"issue":"1","key":"286_CR143","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1210\/jc.2014-2583","volume":"100","author":"Y Xuan","year":"2015","unstructured":"Xuan Y, Sun LH, Liu DM, Zhao L, Tao B, Wang WQ, et al. Positive association between serum levels of bone resorption marker CTX and HbA1c in women with normal glucose tolerance. J Clin Endocrinol Metab. 2015;100(1):274\u201381. https:\/\/doi.org\/10.1210\/jc.2014-2583 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"286_CR144","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00592-011-0324-7","volume":"49","author":"EJ Hamilton","year":"2012","unstructured":"Hamilton EJ, Rakic V, Davis WA, Paul Chubb SA, Kamber N, Prince RL, et al. A five-year prospective study of bone mineral density in men and women with diabetes: the Fremantle Diabetes Study. Acta Diabetol. 2012;49(2):153\u20138. https:\/\/doi.org\/10.1007\/s00592-011-0324-7 .","journal-title":"Acta Diabetol"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-019-00286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13668-019-00286-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-019-00286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T17:39:29Z","timestamp":1663954769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13668-019-00286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1007\/s13668-019-00286-0","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"11 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Rosemary DeLuccia, May Cheung, Rohit Ramadoss, Abeer Aljahdali, and Deeptha Sukumar declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}